TP53BP2 and breast carcinoma: Reduced expression of TP53BP2 has been linked with poor distant recurrence-free surival in breast cancer patients [88] and was observed in metastatic breast cancer samples compared to non-metastatic samples [92], suggesting that TP53BP2 may be associated with breast cancer progression.